Coregen™  is a Bio-Matrix Tissue Reconstruction material.

The product is an injectable gel developed particularly for such joint diseases as osteoarthritis (OA), degenerative joint diseases (DJD) and degenerative meniscopathy.
Because of glucosamine derivatives contained in its formulation, it effectively;
– Prevents cartilage degeneration,
– Helps cartilage regeneration,
– Relieves the pain,
– Renews the cartilage and helps the prevention of joint degeneration. The active pharmaceutical ingredients in Coregen™ have the structure of Glycosaminoglycan (GAG).

The doses of the product which was developed to assist the improvement of the joint tissue in the treatment of osteoarthritis and to support the renewal of the impaired structures of articular cartilage, tendons and synovial liquid due to the disease and to ensure the synthesis of the Glycosaminoglycan (GAG) in the cartilage have a safe, effective and easy administration technology thanks to the content of the Glycosaminoglycan structure. An Effective Mechanism COREGEN™ integrates the glycosaminoglycan (GAGs) of the Chondroitin Sulphate and N-Acetylglucosamine bound to the skeleton structure with the cartilage by way of creating an elastin surface on the area where the joint damage is observed in the active cartilage matrix involving Hyaluronan.
The active substances of Chondroitin Sulphate and N-Acetylglucosamine act as a protective and regenerative agent on the surface of damage.